Harriet De Wit to Substance-Related Disorders
This is a "connection" page, showing publications Harriet De Wit has written about Substance-Related Disorders.
Connection Strength
5.744
-
The mesocorticolimbic system in stimulant use disorder. Mol Psychiatry. 2025 Nov; 30(11):5486-5499.
Score: 0.675
-
Genetic influences on delayed reward discounting: A genome-wide prioritized subset approach. Exp Clin Psychopharmacol. 2019 Feb; 27(1):29-37.
Score: 0.417
-
Does human language limit translatability of clinical and preclinical addiction research? Neuropsychopharmacology. 2018 09; 43(10):1985-1988.
Score: 0.407
-
Acquisition of Conditioning between Methamphetamine and Cues in Healthy Humans. PLoS One. 2016; 11(8):e0161541.
Score: 0.361
-
Extinction of Conditioned Responses to Methamphetamine-Associated Stimuli in Healthy Humans. Psychopharmacology (Berl). 2016 07; 233(13):2489-502.
Score: 0.353
-
A window into the intoxicated mind? Speech as an index of psychoactive drug effects. Neuropsychopharmacology. 2014 Sep; 39(10):2340-8.
Score: 0.306
-
Quantifying reinforcement value and demand for psychoactive substances in humans. Curr Drug Abuse Rev. 2012 Dec; 5(4):257-72.
Score: 0.279
-
Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev. 2012 Jul; 36(6):1565-76.
Score: 0.267
-
Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. Hum Genet. 2012 Jun; 131(6):931-9.
Score: 0.261
-
Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009 Jan; 14(1):22-31.
Score: 0.209
-
Evaluation of the abuse potential of pagoclone, a partial GABAA agonist. J Clin Psychopharmacol. 2006 Jun; 26(3):268-73.
Score: 0.177
-
Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend. 2006 Sep 01; 84(1):1-13.
Score: 0.173
-
Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv. 2004; 50:19-55.
Score: 0.150
-
GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 2002 Feb 01; 65(3):209-20.
Score: 0.131
-
Neural activation during anticipation of monetary gain or loss does not associate with positive subjective response to alcohol in binge drinkers. Drug Alcohol Depend. 2021 01 01; 218:108432.
Score: 0.121
-
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. Addict Biol. 2021 01; 26(1):e12880.
Score: 0.115
-
Multidimensional latent structure of risk-related phenotypes in healthy young adults. Exp Clin Psychopharmacol. 2020 Feb; 28(1):55-64.
Score: 0.114
-
Individual differences in acute effects of drugs in humans: their relevance to risk for abuse. NIDA Res Monogr. 1998 Mar; 169:176-87.
Score: 0.100
-
Considering the context: social factors in responses to drugs in humans. Psychopharmacology (Berl). 2018 04; 235(4):935-945.
Score: 0.100
-
The latent structure of impulsivity: impulsive choice, impulsive action, and impulsive personality traits. Psychopharmacology (Berl). 2016 Sep; 233(18):3361-70.
Score: 0.090
-
Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9.
Score: 0.087
-
A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial. PLoS One. 2015; 10(10):e0140501.
Score: 0.085
-
Interrelationships among parental family history of substance misuse, delay discounting, and personal substance use. Psychopharmacology (Berl). 2016 Jan; 233(1):39-48.
Score: 0.085
-
Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend. 1994 Feb; 34(3):243-51.
Score: 0.076
-
Sex differences in impulsive action and impulsive choice. Addict Behav. 2014 Nov; 39(11):1573-1579.
Score: 0.074
-
Preference procedures for testing the abuse liability of drugs in humans. Br J Addict. 1991 Dec; 86(12):1579-86.
Score: 0.065
-
Diazepam preference in males with and without an alcoholic first-degree relative. Alcohol Clin Exp Res. 1991 Aug; 15(4):593-600.
Score: 0.063
-
Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend. 1991 Jun; 28(1):83-111.
Score: 0.063
-
Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol. 2010 Jul; 21(4):251-77.
Score: 0.059
-
Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):175-80.
Score: 0.057
-
Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict. 2006 Sep-Oct; 15(5):327-35.
Score: 0.045
-
Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl). 2006 May; 185(4):514-23.
Score: 0.044
-
Anticipation of monetary reward in amygdala, insula, caudate are predictors of pleasure sensitivity to d-Amphetamine administration. Drug Alcohol Depend. 2020 01 01; 206:107725.
Score: 0.028
-
Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998 Feb; 59(2):287-93.
Score: 0.025
-
Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. J Psychopharmacol. 2016 Apr; 30(4):330-43.
Score: 0.022
-
Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. 1993 Feb; 31(3):265-80.
Score: 0.018
-
Self-administration of pentobarbital in light and moderate alcohol drinkers. Pharmacol Biochem Behav. 1992 Oct; 43(2):563-9.
Score: 0.017
-
Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers. Anesth Analg. 1992 Apr; 74(4):523-30.
Score: 0.017
-
Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology. 2004 Apr; 70(4):206-15.
Score: 0.010